22 1074 Mrv0541 02231215132 d 20 0 0 1 0 999 V2000型5.9370 -0.8250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.9370 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.6515 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.6515 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 10 1 0 0 0 0 1 19 1 0 0 0 0 2 3 1 0 0 0 0 2 4 1 1 0 0 0 0 2 5 0 0 0 0 3 1 6 0 0 0 0 3 7 1 0 0 0 0 4 8 1 0 0 0 0 4 9 1 0 0 0 0 5 10 1 0 0 0 0 6 11 1 0 0 0 0 7 12 1 0 0 0 0 8 13 1 0 0 0 0 9 14 1 0 0 0 0 10 17 1 0 0 0 0 11 15 1 0 0 0 0 12 15 1 0 0 0 0 13 16 1 0 0 0 0 14 16 1 0 0 0 0 17 18 1 0 0 0 0 18 19 20 20 1 0 0 0 0 1 0 0 0 0 M >结束
DB01074 >
drugbank >
C (C (C1CCCCC1) C1CCCCC1) C1CCCCN1 >
InChI = 1 s / C19H35N c1-3-9-16 (10-4-1) 19 (17-11-5-2-6-12-17) 15-18-13-7-8-14-20-18 / h16-20H 1-15H2 >
CYXKNKQEMFBLER-UHFFFAOYSA-N >
C19H35N >
277.4879 >
277.276950125 >
1 >
55 >
0.9997366501817181 >
36.2110195976158 >
1 >
1 >
0 >
1 >
2 - (2,2-dicyclohexylethyl)哌啶>
5.87 >
5.531308548333334 >
-7.01 >
0 >
1 >
3 >
1 >
10.57935259054534 >
12.03 >
87.22859999999999 >
4 >
0 >
2.72 e-05 g / l >
四氢叶酸>
1 >
DB01074 >
APRD00107 >
批准;临床实验的>
Perhexiline >
Perhexilene;Perhexilina;Perhexiline;Perhexilinum >
马来酸Perhexiline $ $ $ $